ID: MRFR/LS/0249-CR | August 2019 | Region: Global | 148 pages
A yellowish-orange substance present in the human blood is called bilirubin. This natural coloring is secreted by our liver. It is discharged in bile and is formed from the breaking down of hemoglobin. From the blood, it reaches the liver and gets stored there. Bilirubin gets removed from the body through excretory passages. The condition of high bilirubin level is common in infants. It results in the yellowing of skin and eyes. A bilirubin blood test is conducted to check the level of yellow bilirubin in the blood. When the liver is functioning properly, it expels all the bilirubin from the body. In case the level of bilirubin is high, it gets drained from the liver and causes diseases such as jaundice, dark urine, and others. A high bilirubin blood test enables us to monitor the count of bilirubin in the blood, therefore, detects the problems related to gallbladders.
Bilirubin Blood Test Market size is calculated to index a 5.44% CAGR. It is estimated that its market value will shoot up to USD 1,853.2 Million by the year 2027.
Due to the spread of infectious coronavirus, people are facing several respiratory problems. Many patients have reported high blood test bilirubin levels, which is a serious concern. Although the death rate because of rising in bilirubin level is not high.
The government and medical agencies are investing in Research & Development programs. It will make rapid diagnosis easy. Low bilirubin blood test and high bilirubin blood test include a cumbersome process of sample collection, fluid handling, device packaging, etc. Therefore, a need arises to develop more effective ways of conducting the bilirubin blood test with the least spoilage.
The diseases such as jaundice, dark urine, and problems related to the gallbladder, are increasing rapidly. It is leading to the rise in demand for bilirubin blood testing apparatus. New-born children or infants are more prone to such problems because their liver is not absorbing bilirubin properly immediately after their birth. This has boosted the market demand for portable and easy-to-use testing kits. Thus, the bilirubin blood test market size is expected to grow rapidly throughout the forecasted period.
Bilirubin blood test market growth can be attributed to the constant technological changes. The need for developing new apparatus and techniques of testing is increasing so that more accurate and trustworthy results can be drawn. The transferable and easy-to-use testing kits are being developed for this purpose. People are becoming aware and are adapting to a healthy lifestyle. The government of every nation is also investing its resources in healthcare camps where a large number of people are treated. This has amplified the bilirubin blood testing percentage.
Some other sorts of testing techniques that are being used by people or agencies other than the pathological labs or research institutes are proposing a real threat to bilirubin blood testing market size. The test conducted by non-pathological personnel is not trustworthy and can show false results.
Value Chain Analysis
The key players in the field of the bilirubin blood test market are making technological advancements. They are launching such instruments which will require a minimum ounce of blood for testing the level of bilirubin in the blood of a patient. As the cases of jaundice are more in infants and newborns, the companies are developing techniques that will be less painful and will cause no harm to them.
Bilirubin blood test market can be divided into various segments. These are: based on test type, based on product type, based on application, and based on end-users.
Based on test type
Various kinds of tests conducted in bilirubin blood test market are as follows: Total Serum Bilirubin (TSB); Direct/Conjugated Bilirubin Test; Indirect/Unconjugated Bilirubin Test
Based on product type
Based on product type, the bilirubin blood test market is divided into two types, namely, consumables and instruments. Consumables are not reusable materials. Consumables alone accounted for a market stake of 47.37% in the year 2015, which was the highest among all other segments. The instruments can further be classified into analyzers and bilirubin meters.
Based on application
The market is divided into infants or newborn children and adults. The chances of jaundice in pediatrics are more than that of adults, therefore, infants form the largest percentage of the consumers of the bilirubin blood test market.
Based on end-users
Bilirubin blood testing is done at diagnostics centers, pathological labs, and hospitals. Research laboratories and other academic institutions also contribute a large share to the market. Pediatric clinics and child specialist hospitals are also end-user.
Bilirubin blood test market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include North America, Europe, Asia-pacific, and the rest of the world.
North America, which includes the area of the US and Canada, is overshadowing all the other regions. It accounted for a share of 39.10% in the year 2014, which was the largest in the global bilirubin blood test market. The market share of the US alone is anticipated to reach a CAGR of 4.93%.
The European region, which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the bilirubin blood test market. It is presumed that Germany will touch the largest value, accounting for USD 158.6 million, by the end of the year 2027.
Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for bilirubin blood testing. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. The market of these regions will grow with a CAGR of 6.45%. China alone had a market share of 34.10% in the year 2015.
The rest of the world, which includes regions of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.
The list of major key players involved in the global bilirubin blood test market analysis is as follows:
The above-listed companies work on the testing and origination of new equipment and techniques in the field of bilirubin blood testing. They come together in joint ventures, mergers, and, acquisitions, launching new devices. Their main objective is to deliver devices that are cost-effective, hassle-free in operations, and give concrete results.
|Market Size||USD 1,853.2 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Test Type, Product Type, Applications and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Koninklijke Philips N.V. (Noord-Holland), Beckman Coulter, Inc. (US), Thermo Fisher Scientific Inc. (US), Randox Laboratories Ltd. (UK), Hoffmann-La Roche AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Ginevri (Italy), Advanced Instruments (US), Reichert, Inc. (US), Instrumentation Laboratory (US)., AVI Healthcare Pvt. Ltd.|
|Key Market Opportunities||Developing Countries Can Become Potential Market For Advanced Bilirubin Blood Test Devices|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The projected CAGR for the forecast period would be 5.44%.
The bilirubin blood test market valuation would touch USD 1853.2 million.
The total serum bilirubin market share was 47.37%.
The applications involve pediatric/infants and adults.
The report includes hospitals, home healthcare, and pediatric clinics for discussion.
Global Bilirubin Blood Test Market: Competitive Landscape
The global bilirubin blood test market is currently dominated by market players such as Koninklijke Philips N.V, F. Hoffmann-La Roche AG, Beckman Coulter, Inc., and Thermo Fisher Scientific Inc. Prominent market players are engaged in several strategies such as product launches, partnerships, and acquisitions to enhance their presence in the bilirubin blood test market.
Koninklijke Philips N.V and F. Hoffmann-La Roche AG are focused on product launches and partnerships to enhance their market presence. For instance, in November 2016, Koninklijke Philips N.V launched new IntelliSpace Portal 9.0 that will enhance the neurological diagnosis. This portal allows access to clinical applications from any point of the hospital network and provides flexibility to neurologists to access the power of advanced analysis. Additionally, in June 2016, F. Hoffmann-La Roche AG launched the new Cobas e 801 module that would support hospitals and clinics in diagnostic testing with the increasing demand in the field of diagnostics. This new model for diagnostic testing aims to deliver up to 1200 tests, each hour. Moreover, in August 2015, F. Hoffmann-La Roche AG acquired GeneWEAVE BioSciences, Inc. based in Los Gatos, California, US.
Thermo Fisher Scientific Inc. is one of the major market players in the bilirubin blood test market. The company has focused on several strategies such as acquisitions, partnerships, and expansions to strengthen its market position. For instance, in July 2016, the company announced its partnership with HEALTH BioMed to support the development of molecular diagnostics in China. The partnership with BioMed will allow the company to leverage and expand its diagnostics and treatment support in China. Additionally, in September 2016, the company acquired Alfa Aesar, a company based in the UK that is focused on laboratory products and services. In the same period, the company opened its new global headquarters in Waltham, Massachusetts.